Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics

Whether FDG PET/CT can replace bone marrow biopsy (BMBx) is undecided in patients with diffuse large B cell lymphoma (DLBCL). We compared the visual PET findings and PET radiomic features, with BMBx results. A total of 328 patients were included; 269 (82%) were PET-negative and 59 (18%) were PET-pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eun Ji, O, Joo Hyun, Yoon, Hyukjin, Ha, Seunggyun, Yoo, Ie Ryung, Min, Jae Won, Choi, Joon-Il, Choi, Byung-Ock, Park, Gyeongsin, Lee, Han Hee, Jeon, Young-Woo, Min, Gi-June, Cho, Seok-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774933/
https://www.ncbi.nlm.nih.gov/pubmed/35054389
http://dx.doi.org/10.3390/diagnostics12010222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774933/
https://www.ncbi.nlm.nih.gov/pubmed/35054389
http://dx.doi.org/10.3390/diagnostics12010222

Ejemplares similares